Clinical Trials Logo
  1. Home
  2. Diabetes Mellitus, Type 2
  3. NCT00874159
  4. Details
NCT00874159 Clinical Trial

A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in Philippines

Diabetes Mellitus, Type 2 Clinical Trial

— DiabCare Asia  

Official title:
DiabCare Asia 2008 Philippines A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Philippines & To Evaluate Perceptions and Practices of Physicians & Patients About Diabetes Management in Philippines

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00874159
Other study ID # INS-3712
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 2009
Est. completion date October 2009

Study information
Verified date October 2023
Source Novo Nordisk A/S
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is conducted in Asia. The aim of this observational study is to describe the diabetes management, control status and complication profile in a diabetic population of Philippines.

Recruitment information / eligibility
Status Completed
Enrollment 770
Est. completion date October 2009
Est. primary completion date October 2009
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diabetic patients registered in the particular centre for more than 12 months - Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit - Patients willing to sign informed consent form Exclusion Criteria: - Repetition of any patient as patients should not be included twice for any reason - Unwilling to participate or unable to comply with protocol requirements

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• No treatment given
Subject will only fill out a questionaire when entering the observational study.

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Novo Nordisk A/S

Country where clinical trial is conducted

Philippines, 

Outcome
Type Measure Description Time frame Safety issue
Primary Mean age of onset of type 1 diabetes mellitus at baseline visit/study start
Primary Mean age of onset of type 2 diabetes mellitus at baseline visit/study start
Primary Mean duration of treatment of type 2 DM at baseline visit/study start
Primary Percentage of patients on Insulin therapy at baseline visit/study start
Primary Percentage of patients on OAD therapy at baseline visit/study start
Primary Mean duration of diabetes in type 1 and type 2 patients respectively at baseline visit/study start
Primary Mean FPG of diabetic patients at baseline visit/study start
Primary Mean PPG of diabetic patients at baseline visit/study start
Primary Mean HbA1c of diabetic patients at baseline visit/study start
Primary Percentage of diabetic patients with HbA1c target below 7.0% at baseline visit/study start
Primary Percentage of diabetic patients with HbA1c target below 6.5% at baseline visit/study start
Primary Percentage of diabetic patients having dyslipidemia and hypertension at baseline visit/study start
Primary Percentage of diabetic patients having cardiovascular complications at baseline visit/study start
Primary Percentage of diabetic patients having peripheral vascular disease at baseline visit/study start
Primary Percentage of diabetic patients having diabetic nephropathy at baseline visit/study start
Primary Percentage of diabetic patients having diabetic eye complications at baseline visit/study start
Secondary Patients' perception will be analysed through Patient questionnaire measuring: Psychological well-being, Quality of life, Patients' compliant to treatment at baseline visit/study start
Secondary Physician perception of diabetes and its management will be analysed through Physician questionnaire measuring awareness about:o HbA1c test and its goal,Anti-diabetic treatment,Barriers towards optimum diabetes control at baseline visit/study start
Secondary Duration of diabetes associated with highest number of diabetic complications at baseline visit/study start
Secondary Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, nephropathy and retinopathy) at baseline visit/study start
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2

External Links